Main menu

NEW YORK (GenomeWeb) – Macrogen announced today that it has signed a joint research agreement with the National Cancer Center Korea to utilize genome information-based precision medicine to find better diagnostic tools and treatment options for patients with cancer and rare diseases.

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.